Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial

IMPORTANCE: Evidence is needed regarding the introduction of high-risk human papillomavirus (hrHPV) testing into China’s national cervical cancer screening program. OBJECTIVE: To evaluate hrHPV testing as a new screening modality for the national program. DESIGN, SETTING, AND PARTICIPANTS: This popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junji, Zhao, Yuqian, Dai, Yi, Dang, Le, Ma, Li, Yang, Chunxia, Li, Yang, Kong, Linghua, Wei, Lihui, Zhang, Shulan, Liu, Jihong, Xi, Minrong, Chen, Long, Duan, Xianzhi, Xiao, Qing, Abulizi, Guzhalinuer, Zhang, Guonan, Hong, Ying, Gao, Xiaohong, Zhou, Qi, Xie, Xing, Li, Li, Niyazi, Mayinuer, Zhang, Zhifen, Tuo, Jiyu, Ding, Yiling, Si, Manfei, Chen, Fei, Song, Li, Qiao, Youlin, Lang, Jinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774051/
https://www.ncbi.nlm.nih.gov/pubmed/33377903
http://dx.doi.org/10.1001/jamaoncol.2020.6575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774051/
https://www.ncbi.nlm.nih.gov/pubmed/33377903
http://dx.doi.org/10.1001/jamaoncol.2020.6575

Ejemplares similares